|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Respiratory Medicine
:
COPD
COPD patients using beta-agonist inhalers are at risk
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other -- which is prescribed in the majority of cases -- increases respiratory deaths.
Jul 10, 2006, 06:15
Latest Research
:
Respiratory Medicine
:
COPD
Beta-agonists more than double death rate in COPD patients
A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory deaths, but the other -- which is prescribed in the majority of cases -- increases respiratory deaths.
Jul 5, 2006, 15:18
Latest Research
:
Respiratory Medicine
:
COPD
Lung function test underused in patients with COPD
At least two thirds of patients with chronic obstructive pulmonary disease (COPD) do not receive lung function testing that is recommended for the accurate diagnosis and effective management of the disease, suggesting that the majority of patients are diagnosed with COPD based on symptoms alone. New research published in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), finds that only one third of patients recently diagnosed with COPD underwent spirometry, a noninvasive lung function test, to confirm COPD or to manage their condition. Current national guidelines recommend spirometry for the diagnosis and management of COPD.
Jun 14, 2006, 20:14
Latest Research
:
Respiratory Medicine
:
COPD
Wrinkles clue to risk of progressive lung disease (COPD)
Middle aged smokers, who are heavily lined with wrinkles, are five times as likely to have chronic obstructive pulmonary disease, or COPD for short, suggests research published ahead of print in Thorax.
Jun 14, 2006, 20:05
Latest Research
:
Respiratory Medicine
:
COPD
Antibiotics reduce risk of dying from COPD attack by 77 percent
People with chronic obstructive pulmonary disease often experience short term worsening and aggravation of their symptoms. To date, there has been conflicting evidence as to whether these exacerbations should be treated with antibiotic therapy. A new systematic review to be published in The Cochrane Library, Issue 2, 2006 now concludes that they should be used. The researchers found that antibiotics reduce the risk of dying from the attack by 77%, decreases the risk of treatment failure by 53% and decrease the risk of developing pussy sputum by 44%. There is, however, a small increase in the risk of developing diarrhoea. Many people question whether antibiotics should be used to combat exacerbations of COPD. The uncertainty stems from the growing desire to use antibiotics only when necessary, combined with the recognition that up to one third of exacerbations of COPD have are not caused by infections, and some others are due to viral infections.
Jun 12, 2006, 20:21
Latest Research
:
Respiratory Medicine
:
COPD
Women with chronic obstructive pulmonary disease (COPD) fare worse than men
Women with chronic obstructive pulmonary disease (COPD) fare worse than men both in terms of the severity of their disease and their quality of life. These differences may play a role in the increased death rate seen among female patients with COPD, said researcher Claudia Cote, M.D., Assistant Professor of Medicine at the University of South Florida in Tampa. The researchers studied 85 women, and compared them with 95 men who had the same levels of COPD severity according to guidelines of the Global Initiative for Chronic Lung Disease (GOLD). They found that female patients were significantly younger than male patients with the same severity of disease. The women had lower lung function, more trouble breathing, and reported a worse quality of life. The women also received a worse score on the BODE index, which looks at lung function, nutritional status, symptoms and exercise capacity in order to measure a COPD patient's disease severity and predicted survival.
Jun 12, 2006, 20:02
Latest Research
:
Respiratory Medicine
:
COPD
Breathing Heliox 28 significantly improve the exercise performance in COPD
Breathing a special gas mixture may significantly improve the exercise performance of individuals with severe chronic obstructive pulmonary disease (COPD). During an endurance walking test, the patients found that they could improve their walking distance by 64 percent with less shortness of breath.
Apr 15, 2006, 18:48
Latest Research
:
Respiratory Medicine
:
COPD
Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
The combination of two existing clinical treatments, salmeterol and fluticasone propionate, can significantly reduce inflammatory cells in the airways of current and former smokers being treated for moderate to severe chronic obstructive pulmonary disease (COPD).
Apr 3, 2006, 06:48
Latest Research
:
Respiratory Medicine
:
COPD
COPD is slated to become world's biggest killer by 2020 - WHO
A smoking-related illness that narrows one's breathing passage is slated to become the world's third biggest killer by 2020, according to the WHO. Called Chronic Obstructive Pulmonary Disease (COPD), the ailment entails two specific health problems: chronic-obstructive bronchitis and emphysema of the lungs.
Mar 13, 2006, 20:31
Latest Research
:
Respiratory Medicine
:
COPD
Study Shows Benefits of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Researchers who designed two different studies to reduce potentially biased results among chronic obstructive pulmonary disease (COPD) patients who used inhaled corticosteroids (ICS) reported a 30 percent reduction in risk for either rehospitalization or death from the disease.
Aug 15, 2005, 18:02
Latest Research
:
Respiratory Medicine
:
COPD
M. catarrhalis, a
"Harmless" Bacterium Found to Cause 10 Percent of COPD Flare-Ups
A ubiquitous bacterial strain thought to be uninvolved in chronic obstructive pulmonary disease (COPD) in fact is responsible for 2-4 million flare-ups of the condition that occur annually in the United States, researchers from the University at Buffalo have shown.
Jul 21, 2005, 23:23
Latest Research
:
Respiratory Medicine
:
COPD
AD 237 : An Inhaled Long-acting Anti-muscarinic for the Treatment of Chronic Obstructive Pulmonary Disease in Phase II
Novartis announced that it has signed a global development and commercialization agreement with Vectura Group plc and Arakis Ltd. for AD 237, an inhaled, long-acting, anti-muscarinic agent for the treatment of chronic obstructive pulmonary disease (COPD).
Apr 18, 2005, 09:03
Latest Research
:
Respiratory Medicine
:
COPD
Data shows care of patients with COPD not good enough in UK
More than one in ten patients with Chronic Obstructive Pulmonary Disease (COPD) admitted to hospital in UK is dead within 90 days of admission, and over 1 in 3 are readmitted to hospital during that time.
Feb 11, 2005, 21:07
|
